News

Continued understanding of the ADME properties of ADCs entering clinical evaluations should provide additional insight into attributes that may be necessary for clinical success.

Company's wholly owned subsidiary Shanghai SynTheAll Pharmaceutical (STA) passed an FDA inspection in July for the manufacture of the active pharmaceutical ingredient (API) for a branded commercial drug.

Findings to answer questions about addition of targeted therapies in earlier stage disease and help understand the prevalence and natural history of these genomic changes in earlier stage lung cancer.

The company expands capabilities with the addition of two new 2,000l single-use bioreactors.

The collaboration will support MMV’s Malaria and Pathogen Box initiatives.

Researchers have discovered a previously unknown cardiac molecule that could provide a key to treating, and preventing, heart failure.

Regeneron Pharmaceuticals' EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Diabetic Macular Edema (DME).

Avastin is the first biologic medicine approved in combination with chemotherapy to help women with this type of cancer live longer than with chemotherapy alone.

Vaccine developed by NIH scientists performs well in early clinical trial.

The agreement provides researchers with an integrated and fully automated ISH solution.